About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
AZN - Astrazeneca PLC| Previous Close | $55.94 | Open | $56.76 |
| Volume | 2.93M | Market Cap | 146.819B |
| Yield | 2.45 % | Last Dividend | $1.37 |
| LYNPARZA?? (olaparib) Reduced the Risk o... | 11:30 AM |
| WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca and Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced final results... | |
| There's a lull in the Russia vaccine aff... | 6:07 AM |
| By Andrew E KramerMOSCOW: More than a month after becoming the first country to approve a coronavirus vaccine, Russia has yet to administer it to a la... | |
| AstraZeneca reveals vaccine trial bluepr... | 2:31 AM |
| By Denise Grady, Katherine J. Wu and Sharon LaFraniereAstraZeneca revealed details of its large coronavirus vaccine trials Saturday, the third in a wa... | |
| US coronavirus vaccine trial on hold aft... | 09/19/20 |
| Experts have voiced concerns about AstraZeneca???s vaccine trials after the company confirmed two UK volunteers suffered serious neurological illnesse... | |
| AstraZeneca, Under Fire for Vaccine Safe... | 09/19/20 |
| Experts are concerned that the company has not been more forthcoming about two participants who became seriously ill after getting its experimental va... | |
| Top nine candidates in the vaccine race | 09/18/20 |
| According to the updated list of the WHO, nine vaccine candidates are in phase 3 trials for Covid-19 ??? in a record eight months since the pandemic h... | |
| Global Clinical Stage Partnering Terms a... | 09/18/20 |
| DUBLIN , Sept. 18, 2020 /PRNewswire/ -- The "Global Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2014-2020" report has been ad... | |
| Talks on to bring Russia's vaccine: Govt | 09/18/20 |
| NEW DELHI: The Centre is in consultations with the Russian government for exploring the possibility of cooperation between the two countries for advan... | |
| AstraZeneca's Lynparza shows positive ef... | 09/18/20 |
| AstraZeneca (NYSE:AZN) and Merck (NYSE:MRK) announce that LYNPARZA demonstrated a long-term progression-free survival (PFS) benefit versus placebo as ... | |
| AstraZeneca???s Imfinzi Trial Shows Surv... | 09/18/20 |
| AstraZeneca said that additional data from the Phase 3 trial of its Imfinzi treatment showed ???unprecedented??? survival in unresectable, Stage 3 cel... | |
| Internal AstraZeneca safety report sheds... | 09/17/20 |
| CNN has obtained an internal safety report by pharmaceutical giant AstraZeneca that sheds light on the neurological condition suffered by one of the p... | |
| Can't build DRL earnings hopes on vaccin... | 09/17/20 |
| Vodafone will continue to remain a trading bet as long as we do not get a greater clarity on its balance sheet, says the analyst, asksandipsabharwal.c... | |
| Dogma Therapeutics Announces Global Acqu... | 09/17/20 |
| CAMBRIDGE, Mass., Sept. 17, 2020 /PRNewswire/ -- Dogma Therapeutics ("Dogma") has reached an agreement for the acquisition of its oral PCSK9 program b... | |
| Major pharma companies including Novarti... | 09/17/20 |
| Pharmaceutical companies including Novartis, Merck, and AstraZeneca have successfully deployed a federated learning platform for drug discovery. | |
| Covid vax to be available by 'start of n... | 09/17/20 |
| New Delhi, Sep 17 (IANS) Union Health Minister Harsh Vardhan on Thursday said that the coronavirus vaccine will be made available in the country by th... | |
| Currency rates for Sept. 17 | 09/17/20 |
| The official exchange rate of the US dollar and euro against Azerbaijani manat was set at 1.7 manats and 1.9988 manats respectively for Sept.17. | |
| AstraZeneca Trial Participant Adverse Ev... | 09/16/20 |
| AstraZeneca Plc???s (NYSE: AZN ) vaccine didn't likely cause the adverse events that suspended the late-stage human trials of the drug, according to O... | |
| Global Antibiotics Market- Featuring Abb... | 09/16/20 |
| LONDON--(BUSINESS WIRE)-- #AntibioticsMarket--The Global Antibiotics Market will grow by USD 4.44 bn during 2020-2024 | |
| AstraZeneca???s trial illnesses may not ... | 09/16/20 |
| The serious side effects that prompted AstraZeneca to pause its coronavirus vaccine trial likely weren???t caused by the shot itself, according to doc... | |
| AstraZeneca COVID-19 vaccine trial 'unli... | 09/16/20 |
| AstraZeneca's global trials were paused on September 6 after a participant in its UK trial suffered a suspected serious adverse reaction. | |
| Covid-19: Serum gets DCGI nod to restart... | 09/16/20 |
| The DCGI had pulled up Serum for failing to inform them about AstraZeneca pausing the clinical trials and failing to submitting casualty analysis of t... | |
| AstraZeneca Gets India Go-Ahead To Resum... | 09/16/20 |
| AstraZeneca plc (NYSE: AZN ) COVID-19 vaccine clinical trial is set to resume in India after local partner Serum Institute of India received the go-ah... | |
| Former FDA Executive on COVID-19 and Con... | 09/16/20 |
| Former FDA Associate Commissioner on COVID-19, Vaccines and Convalescent Plasma Authorization: Margin of Error and Distribution; AstraZeneca, Moderna,... | |
| Pfizer COVID-19 vaccine trial reports no... | 09/16/20 |
| Safety has been a paramount concern since AstraZeneca paused tests of the vaccine it's co-developing with the University of Oxford following an advers... | |
| Currency rates for Sept. 16 | 09/16/20 |
| The official exchange rate of the US dollar and euro against Azerbaijani manat was set at 1.7 manats and 2.0141 manats respectively for Sept.16. | |
| Date | 04/12/2019 (AMC) | Est. (EPS/Rev.) | $1.37 |
| Actual (EPS/Rev.) | $2.5B | EPS (TTM) | $??? |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Alpha Swing Trades | Jonathan | 68.00 % | Follow |
| LavaPit | Steve Pitkin | 57.00 % | Follow |
| Best Trading Ideas | Best Trading Ideas | 53.00 % | Follow |
| Optioneering-W | Sam Allen | 38.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
